Delivery Order SPE2DB24D3013-SPE2DB25FFMAR
Award Date
5/29/25
Potential Completion Date
6/20/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $14,428.06 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, with a value of $14,428.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025, and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm-fixed-price delivery order is for TABRECTA 200 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is a delivery order valued at $13,094.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through November 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $14,428.06 and a performance period through July 21, 2025. This contract is not set aside and was awarded through open competition. AmerisourceBergen...
This is a delivery order (SPE2DB25FDX38) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TABRECTA 200 MG TABLET UU 56S. The order is a firm-fixed-price contract with a ceiling value of $13,094.84 and an ultimate completion date of November 14, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,094.84 firm fixed-price delivery order is for the supply of 4566306589 TABRECTA 200 MG TABLET UU 56S, with a completion date of November 25, 2024. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Department of Defense (DoD) agency, Medical Supply Chain, to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $6,547.42 firm fixed-price delivery order is for the supply of 4564654292 TABRECTA 200 MG TABLET UU 56S, with a completion date of June 11, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of the pharmaceutical product TABRECTA 200 MG TABLET UU 56S, with a ceiling value of $13,094.84 and a period of performance through April 10, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...